Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.79 |
| ▸ | ACHE | P22303 | 4/20 | 0.75 |
| ▸ | MAOB | P27338 | 1/20 | 0.74 |
| ▸ | BCHE | P06276 | 1/20 | 0.73 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | TYR | P14679 | 2/20 | 0.61 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Feruloyl Serotonin SCHEMBL12063415 | 1.00 | PTGS2 (0.79) | PTGS2ACHEMAOBBCHEMEN1 | |
| N-Feruloyl Serotonin SCHEMBL30037765 | 1.00 | PTGS2 (0.79) | PTGS2ACHEMAOBBCHEMEN1 | |
| N-Isoferuloyl Serotonin SCHEMBL803830 | 0.93 | PTGS2 (0.79) | PTGS2ACHEMAOBBCHEMEN1 | |
| SCHEMBL10071694 | 0.92 | ACHE (0.88) | PTGS2ACHEMAOBBCHEMEN1 | |
| SCHEMBL803753 | 0.91 | PTGS2 (0.76) | PTGS2ACHEMAOBBCHEMEN1 | |
| N-Sinapoyl Serotonin SCHEMBL803240 | 0.90 | MAOB (0.74) | PTGS2ACHEMAOBBCHEMEN1 | |
| SCHEMBL4434094 | 0.90 | ACHE (0.88) | PTGS2ACHEMAOBBCHEMEN1 | |
| SCHEMBL10070987 | 0.90 | ACHE (0.88) | PTGS2ACHEMAOBBCHEMEN1 | |
| SCHEMBL31634290 | 0.90 | ACHE (0.88) | PTGS2ACHEMAOBBCHEMEN1 | |
| N-Caffeoylserotonin SCHEMBL803616 | 0.88 | PTGS2 (1.00) | PTGS2ACHEMAOBBCHEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120201991-A | Composition for improving skin wrinkles | 株式会社LG生活健康 | 2025-06-24 | — | — | CN | claimed |
| WO-2024106669-A1 | COMPOSITION FOR IMPROVING SKIN WRINKLES | 주식회사 엘지생활건강 | 2024-05-23 | — | — | WO | claimed |
| WO-2024105703-A1 | NOVEL OPHTHALMIC FORMULATION | FERTIS INDIA PVT LTD (IN) | 2024-05-23 | — | — | WO | claimed |
| EP-3253229-B1 | PROCESS FOR THE FRACTIONATION OF SEEDS FROM OLEAGINOUS PLANTS. | NOVAMONT SPA (IT) | 2022-12-28 | — | — | EP | claimed |
| US-8309576-B2 | Method of treating inflammatory bowel disease | AJINOMOTO CO., INC. (JP) | 2012-11-13 | — | — | US | claimed |
| US-8080564-B2 | Hemodynamics improving agent | AJINOMOTO CO., INC. (JP) | 2011-12-20 | — | — | US | claimed |
| US-7767236-B2 | Plant seed extract composition and process for producing the same | AJINOMOTO CO., INC. (JP) | 2010-08-03 | — | — | US | claimed |
| US-20090156657-A1 | ANTI-INFLAMMATORY COMPOSITION | AJINOMOTO CO., INC. (JP) | 2009-06-18 | — | — | US | claimed |
| US-20080171781-A1 | HEMODYNAMICS IMPROVING AGENT | AJINOMOTO CO., INC. (JP) | 2008-07-17 | — | — | US | claimed |
| US-7357951-B2 | Composition for preventing atherosclerosis | AJINOMOTO CO., INC. (JP) | 2008-04-15 | — | — | US | claimed |
| US-20060257540-A1 | Plant seed extract composition and process for producing the same | AJINOMOTO CO., INC. (JP) | 2006-11-16 | — | — | US | claimed |
| US-7084322-B2 | Method for biosynthesizing the serotonin derivatives in plants | CHONNAM NATIONAL UNIVERSITY (KR) | 2006-08-01 | — | — | US | claimed |
| EP-1679079-A1 | PLANT SEED EXTRACT COMPOSITION AND PROCESS FOR PRODUCING THE SAME | Ajinomoto Co., Inc. (JP) | 2006-07-12 | — | — | EP | claimed |
| US-20040268437-A1 | Method for biosynthesizing the serotonin derivatives in plants | CHONNAM NATIONAL UNIVERSITY (KR) | 2004-12-30 | — | — | US | claimed |
| WO-2004113545-A1 | METHOD FOR BIOSYNTHESIZING THE SEROTONIN DERIVATIVES IN PLANTS | CHONNAM NATIONAL UNIVERSITY (KR) | 2004-12-29 | — | — | WO | claimed |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| EP-4654815-A1 | UNSATURATED ALDEHYDES VIA RICE BIOTRANSFORMATION | Symrise AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| US-20040268437-A1 | Method for biosynthesizing the serotonin derivatives in plants | CHONNAM NATIONAL UNIVERSITY (KR) | 2004-12-30 | — | — | US | disclosed |
| WO-2004113545-A1 | METHOD FOR BIOSYNTHESIZING THE SEROTONIN DERIVATIVES IN PLANTS | CHONNAM NATIONAL UNIVERSITY (KR) | 2004-12-29 | — | — | WO | disclosed |
| WO-2004113545-A1 | METHOD FOR BIOSYNTHESIZING THE SEROTONIN DERIVATIVES IN PLANTS | CHONNAM NATIONAL UNIVERSITY (KR) | 2004-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | PTGS2 4537/4885ACHE 27/4885MAOB 293/4885 |
| US-20090156657-A1 | ANTI-INFLAMMATORY COMPOSITION | VCAM1, ICAM1, TPH1 | PTGS2 142/4885ACHE 990/4885MAOB 130/4885 |
| US-20080171781-A1 | HEMODYNAMICS IMPROVING AGENT | TPH1, HTR1A, VASP | PTGS2 85/4885ACHE 107/4885MAOB 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.